transmed research

Transmed Research has been set up to join excellence in research with a market-oriented approach.

Our purpose is to shorten the translational process and the timing for the design and development of new products offering innovative, flexible and efficient methodologies and services based on high-throughput analysis for animal behavior, cell-based assays, clinical biomarkers.

TransMed Research supports all types of in vitro and in vivo studies, through preliminary non-GLP toxicology and efficacy studies to formal GLP studies. TransMed Research supplies studies and tests ready to be included in the applications to regulatory agencies like AIFA (Italian Pharma Agency), EMA (European Medicine Agency), FDA (Food and Drug Administration) to be authorized to market pharmaceutical products.

TransMed Research is a partner for public health authorities, private health care and insurance companies, to study risk factors related to the life style and co-morbilities, and proposes best practices and guidelines. TransMed Research is also an experienced partner for grant applications at national and international level.

-Our Expertise

TMR know-how is based on 20 years of research experience in academic and nonprofit organizations. Our expertise and dedicated infrastructure put together:

  • • cross competences on a wide range of fast developing and advanced topics, starting from the project design up to the statistical data analysis
  • • strong research background in preclinical studies in neurology, inflammation, endocrinology, regenerative medicine
  • • high-tech, updated instruments
  • • certified procedures
  • • flexibility and efficiency to meet market expectations This enriches our certified services with the added value of research vision, thus coupling GLP services with discovery design, grant application support, and results valorization. Our choice is not to sell just services; we propose medium-term scientific partnerships and joint development of projects.


Currently we work with:

  • • CHIESI FARMACEUTICI S.p.A., Parma Italy
  • • IGEA S.p.A., Carpi (Modena), Italy
  • • Istituto Rinaldi Fontani srl, Firenze, Italy
  • • RGMD S.p.A., Genova, Italy
  • • CT LABORATORIES srl, Sanremo (Imperia), Italy
  • • Health Ricerca & Sviluppo, Bologna, Italy
  • • Health Sciences and Technologies – Interdepartmental Center for Industrial Research (HST-ICIR), University of Bologna, Italy
  • • Dept. of Life Sciences and Biotechnology, University of Ferrara, Italy
  • • Dept. of Medical Sciences, University of Ferrara, Italy We have also worked with:
  • • Abiogen Pharma S.p.A., Pisa, Italy
  • • Nikon Italia, Firenze, Italy • NEN Dupont Italia, Milano, Italy
  • • Sigma-Tau S.p.A., Pomezia, Italy
  • • Glaxo-Wellcome S.p.A., Medicine Research Centre, Verona, Italy
  • • Pfizer Italia, Roma • Pharmacia&Upjong, Milano, Italy


TMR laboratory has been approved as test facility according to GLP (Good Laboratory Practices) by the Italian Health Ministry (competent authority).

TransMed Research is working in the strict respect of the “3R” rules as ethical framework for conducting scientific experiments using animals humanely (Replacement - use of non-animal methods; Reduction - methods which reduce the number of animals use; Refinement - methods which improve animal welfare).